FDA Approves Bonsity (teriparatide injection) to Treat Osteoporosis

SAN DIEGO, October 7, 2019— Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA) has approved the new drug application (“NDA”) for Bonsity (PF708) submitted under the 505(b)(2)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news